Safety and Efficacy of Convalescent Plasma for Severe COVID-19: Interim Report of a Multicenter Phase II Study from Saudi Arabia

Safety and Efficacy of Convalescent Plasma for Severe COVID-19: Interim Report of a Multicenter Phase II Study from Saudi Arabia

Objective: To present the interim findings from a national study investigating the safety and efficacy of convalescent plasma (CP) containing detectable IgG antibodies as a treatment strategy for severe coronavirus disease 2019 (COVID-19). Trial Design and Participants: An open label, two-arm, phas...

Full description

Bibliographic Details
Main Authors: Nawal AlShehry, Syed Ziauddin A Zaidi, Ahmed AlAskar, Abdurahman Al Odayani, Jawaher Mubarak Alotaibi, Ahmed AlSagheir, Ayman Al-Eyadhy, Saud Balelah, Abdul Salam, Abdul Rehman Zia Zaidi, Diea Alawami, Mohammed S Alshahrani, Nour AlMozain, Yem M Abulhamayel, Reem Al Qunfoidi, Mona Alfaraj, Nahid Qushmaq, Rehab Alansari, Afra Dayel, Ghada Elgohary, Ahmed Al Bahrani, Arwa A Nabhan Abdelhameed, Hazza Abdullah AlZahrani, Hanan Alturkistani, Nada AlShehry, Mohammed Abdulhameed Albalawi, Ibrahim Elalfy, Hind Alhumaidan, Hani Al-Hashmi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Saudi Journal of Medicine and Medical Sciences
Subjects:
antibodies
convalescent plasma
covid-19
sars-cov-2
saudi arabia
Online Access:http://www.sjmms.net/article.asp?issn=1658-631X;year=2021;volume=9;issue=1;spage=16;epage=23;aulast=AlShehry

Internet

http://www.sjmms.net/article.asp?issn=1658-631X;year=2021;volume=9;issue=1;spage=16;epage=23;aulast=AlShehry

Similar Items